Efficacy of hypericum extract Ws® 5570 compared with paroxetine in patients with a moderate major depressive episode-a subgroup analysis

被引:0
作者
Holsboer-Trachsler, E. [1 ]
Seifritz, E. [2 ]
Hatzinger, M. [3 ]
机构
[1] Univ Basel, Psychiat Clin UPK, Basel, Switzerland
[2] Univ Zurich, Hosp Psychiat, Dept Psychiat Psychotherapy & Psychosomat, Zurich, Switzerland
[3] Univ Basel, Psychiat Serv Solothurn, Solothurn, Switzerland
关键词
D O I
10.1016/j.eurpsy.2017.01.716
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
EV0386
引用
收藏
页码:S529 / S530
页数:2
相关论文
共 25 条
  • [21] Efficacy of aripiprazole augmentation in Japanese patients with major depressive disorder: A subgroup analysis and Montgomery-Asberg Depression Rating Scale and Hamilton Rating Scale for Depression item analyses of the Aripiprazole Depression Multicenter Efficacy study
    Ozaki, Norio
    Otsubo, Tempei
    Kato, Masaki
    Higuchi, Teruhiko
    Ono, Hiroaki
    Kamijima, Kunitoshi
    [J]. PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2015, 69 (01) : 34 - 42
  • [22] Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A Subgroup Analysis of Two Phase 3 Studies
    Linda Stein Gold
    Andreas Pinter
    April Armstrong
    Matthias Augustin
    Petr Arenberger
    Neil Bhatia
    Morten Praestegaard
    Lars Iversen
    Adam Reich
    [J]. Dermatology and Therapy, 2023, 13 : 2031 - 2044
  • [23] Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A Subgroup Analysis of Two Phase 3 Studies
    Gold, Linda Stein
    Pinter, Andreas
    Armstrong, April
    Augustin, Matthias
    Arenberger, Petr
    Bhatia, Neil
    Praestegaard, Morten
    Iversen, Lars
    Reich, Adam
    [J]. DERMATOLOGY AND THERAPY, 2023, 13 (09) : 2031 - 2044
  • [24] LESSONS LEARNT FROM AN 8-WEEK RANDOMIZED, DOUBLE-BLIND, CONTROLLED, PARALLEL GROUPS STUDY ON THE EFFICACY AND SAFETY OF AGOMELATINE (25-50 MG/DAY ORALLY) COMPARED TO PLACEBO IN BIPOLAR I PATIENTS WITH A CURRENT MAJOR DEPRESSIVE EPISODE
    Boyce, P.
    Yatham, L.
    Picarel-Blanchot, F.
    de Bodinat, C.
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2018, 52 : 137 - 137
  • [25] Efficacy and safety of esketamine nasal spray in addition to standard of care in patients with major depressive disorder who have active suicidal ideation with intent: A subgroup analysis of the Asian cohort of ASPIRE I (a randomized, double-blind, placebo-controlled study)
    Hong, Jin Pyo
    Malek, Akramul Zikri Abd
    Li, Cheng-Ta
    Paik, Jong-Woo
    Sulaiman, Ahmad Hatim
    Madriaga, Gilbert
    Zhuo, Jianmin
    Siggins, Sarah
    Fu, Dong-Jing
    Ju, Po-Chung
    [J]. ASIA-PACIFIC PSYCHIATRY, 2023, 15 (04)